Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Peker (Istanbul, Turkey), E. Thunström (Gothenburg, Sweden), H. Glantz (Lidköping, Sweden), C. Eulenburg (Groningen, Netherlands). Effect of obstructive sleep apnoea on cardiovascular outcomes in patients with acute coronary syndrome: a secondary analysis of the RICCADSA trial. 4993

Member's Comments

No comment yet.

Related content which might interest you: Effect of obstructive sleep apnoea on severity and short-term prognosis of acute coronary syndrome Source: Eur Respir J 2015; 45: 419-427 Year: 2015 Predictors of obstructive sleep apnoea in patients admitted for acute coronary syndrome Source: Eur Respir J , 49 (3) 1600550; DOI: 10.1183/13993003.00550-2016 Year: 2017 Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond Year: 2021 The impact of obstructive sleep apnea in case of acute coronary syndrome Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Treatment of obstructive sleep apnea improves cardiovascular outcome. A prospective study Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006 Systematic coronary risk evaluation among obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Variance over time of the obstructive sleep apnoea syndrome (OSAS) in patients with acute stroke Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011 Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006 Adherence to CPAP treatment in patients with coronary artery disease and obstructive sleep apnoea without sleepiness: a preliminary report from the riccadsa trial Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Screening of sleep apnea syndrome in patients with acute coronary syndrome Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010 CPAP does not reduce inflammatory biomarkers in coronary artery disease patients with nonsleepy obstructive sleep apnoea: a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Early signs of cardiovascular system dysfunction in obstructive sleep apnea (OSA) patients before clinical manifestation Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Gout increases the risk of coronary heart disease among patients with obstructive sleep apnea: A nationwide population-based cohort study Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity Year: 2015 High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Effect of central sleep apnoea on severity and short-term prognosis of acute coronary syndrome Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016 Treatment control in risk patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 411s Year: 2006